NCT07718217Active, not recruiting
Mindfulness-Based Education For Women With Polycystic Ovary Syndrome
The Effect Of Mindfulness-Based Education For Women With Polycystic Ovary Syndrome On Menstrual Symptoms, Stress, And Quality of Life: A Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
Polycystic ovary syndrome (PCOS), also known as polyendocrine metabolic ovarian syndrome (PMOS), is the most common endocrinologic disorder to affect women. Despite this, the disease's pathophysiology remains unclear. This has hindered the diagnosis of the disease and the appropriate treatment for millions of individuals. The long-term health sequelae associated with PCOS, future directions, and areas of needed research in this often-overlooked disease. Women with PCOS may experience menstrual symptoms, increased stress, and difficulties in managing the physical and emotional effects of the condition. Supportive approaches that improve symptom management and quality of life may be beneficial in addition to routine care. The aim of this randomized controlled study is to evaluate the effect of mindfulness-based PCOS education on menstrual symptoms, stress levels, and quality of life in women with PCOS. The study will examine whether a structured mindfulness-based education program can support women in managing PCOS-related symptoms and improving their overall well-being. Women diagnosed with PCOS who meet the study eligibility criteria will be invited to participate. Participants will be randomly assigned to either the intervention group or the control group. Participants in the intervention group will receive a mindfulness-based PCOS education program, while those in the control group will receive routine care without it. Researchers will assess participants' menstrual symptoms, stress levels, and quality of life using validated measurement tools before and after the intervention. The findings of this study will provide information about the potential role of mindfulness-based education as a supportive approach in the management of PCOS and may contribute to the development of patient-centered education programs for women with PCOS.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 78 (estimated)
- First submitted
- 17 Jul 2026
- Start date
- 20 Jul 2026
- Primary completion date
- 30 Aug 2026
- Lead sponsor
- Aydin Adnan Menderes University
- NCT number
- NCT07718217
What you commit to
- Study type: Interventional
- Planned participants: 78
- From 20 Jul 2026 to the primary completion date, 30 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having previously received structured mindfulness training or participated in a mindfulness-based program during the study period.
Other illness
- Having a severe psychiatric disorder or cognitive impairment that may interfere with participation.
- Having a serious chronic medical condition that could affect study outcomes or prevent participation in the intervention.
Other
- Currently pregnant or breastfeeding.
- Currently participating in another interventional research study.
- Being unable to attend the online education sessions or complete the study assessments.
- Declining or withdrawing informed consent at any stage of the study.
Who the study is looking for
- Self-identify as female.
- Be of reproductive age (18-49 years).
- Have a confirmed diagnosis of Polycystic Ovary Syndrome (PCOS) based on the Rotterdam criteria.
- Be able to read, understand, and communicate in Turkish.
- Have access to the internet and a device capable of participating in online education sessions.
- Be willing to attend the four-week online education program and complete all study assessments.
- Provide written informed consent before participation.
Age in the registry: 18 years to 49 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bursa Uludag University obstetrics and gynecology clinic Coordinator of this site? Confirm its status | Bursa | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.